Page last updated: 2024-09-03
win 56291 and valine
win 56291 has been researched along with valine in 1 studies
Compound Research Comparison
| Studies (win 56291) | Trials (win 56291) | Recent Studies (post-2010) (win 56291) | Studies (valine) | Trials (valine) | Recent Studies (post-2010) (valine) |
|---|---|---|---|---|---|
| 5 | 0 | 1 | 15,465 | 1,176 | 3,932 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Aguayo, E; Birkus, G; Cihlar, T; Jordan, R; Lee, G; Mello, C; Rodriguez, M | 1 |
Other Studies
1 other study(ies) available for win 56291 and valine
| Article | Year |
|---|---|
Multiple classes of antiviral agents exhibit in vitro activity against human rhinovirus type C.
Topics: Antiviral Agents; Common Cold; Dose-Response Relationship, Drug; HeLa Cells; Humans; In Vitro Techniques; Isoxazoles; Oxadiazoles; Oxazoles; Phenylalanine; Piperidines; Pyridazines; Pyrrolidinones; Replicon; Rhinovirus; RNA, Viral; Tubercidin; Valine; Virus Replication | 2014 |